SAMRAT PHARMACHEM
Back to Balance Sheet
|
SAMRAT PHARMACHEM Last 5 Year Deferred Tax Assets / Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹0.11 Cr | ₹0.34 Cr | ₹0.25 Cr | ₹0.46 Cr | ₹0.43 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of SAMRAT PHARMACHEM ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹0.11 Cr |
| Mar2024 | ₹0.34 Cr |
| Mar2023 | ₹0.25 Cr |
| Mar2022 | ₹0.46 Cr |
| Mar2021 | ₹0.43 Cr |
How is Deferred Tax Assets / Liabilities of SAMRAT PHARMACHEM Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹0.11 Cr | -66.96 | |
| Mar2024 | ₹0.34 Cr | 32.28 | |
| Mar2023 | ₹0.25 Cr | -44.90 | |
| Mar2022 | ₹0.46 Cr | 6.47 | |
| Mar2021 | ₹0.43 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of SAMRAT PHARMACHEM
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SAMRAT PHARMACHEM | ₹64.0 Cr | 0.7% | -1.4% | -38.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,603.0 Cr | -5.6% | -2.5% | -1.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹155,485.0 Cr | -2.6% | -8.7% | 1.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,009.0 Cr | -7.2% | -8% | 27.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,628.0 Cr | -6.5% | -5.4% | 3.9% | Stock Analytics | |
| CIPLA | ₹96,400.8 Cr | -4.1% | -11.5% | -19% | Stock Analytics | |
SAMRAT PHARMACHEM Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SAMRAT PHARMACHEM | 0.7% |
-1.4% |
-38.7% |
| SENSEX | -1% |
-10.9% |
-6% |
You may also like the below Video Courses